261 related articles for article (PubMed ID: 35860559)
1. Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma.
Zhu T; Wang T; Feng Z; Gao F; Zhang J; Jin C; Tian H; Xu J; Chen H; Ou Q; Wang J; Xu G; Lu L
Front Oncol; 2022; 12():880100. PubMed ID: 35860559
[TBL] [Abstract][Full Text] [Related]
2. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
Front Genet; 2022; 13():978840. PubMed ID: 36186442
[TBL] [Abstract][Full Text] [Related]
3. Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Sun W; Hu C; Wang T; Wang J; Zhang J; Gao F; Ou Q; Tian H; Jin C; Xu J; Zhang J; Xu GT; Lu L
Front Oncol; 2021; 11():744331. PubMed ID: 34796110
[TBL] [Abstract][Full Text] [Related]
4. Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma.
Zhang M; Liu YF; Gao Y; Zhao C; Chen M; Pan KH
Transl Oncol; 2023 Aug; 34():101693. PubMed ID: 37315507
[TBL] [Abstract][Full Text] [Related]
5. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
Cheng L; Mi J; Zhang J; Huang H; Mo Z
Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
[TBL] [Abstract][Full Text] [Related]
6. Low
Xie Z; Chen N
Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311
[TBL] [Abstract][Full Text] [Related]
7. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
8. High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.
Qiu J; Wang Z; Zhao L; Zhang P; Xu Y; Xia Q
Front Mol Biosci; 2023; 10():1201155. PubMed ID: 37529377
[No Abstract] [Full Text] [Related]
9. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
10. TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.
Fan X; Liu B; Wang Z; He D
Aging (Albany NY); 2021 Mar; 13(6):8541-8562. PubMed ID: 33714201
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
12. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
Sun X; Liu P
Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of
Liu W; Xiao Z; Dong M; Li X; Huang Z
Oncol Lett; 2024 Mar; 27(3):97. PubMed ID: 38288038
[TBL] [Abstract][Full Text] [Related]
14. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
Front Genet; 2023; 14():1109991. PubMed ID: 36992705
[No Abstract] [Full Text] [Related]
15. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.
Weng J; Huang Z; Li Q; Huang Y; Chen S
Int J Med Sci; 2023; 20(8):1046-1059. PubMed ID: 37484803
[No Abstract] [Full Text] [Related]
17. Up-regulation expression and prognostic significance of Syntaxin4 in kidney renal clear cell carcinoma.
He L; Jiang H; Lai Z; Zhong Z; Huang Z
BMC Cancer; 2021 Sep; 21(1):992. PubMed ID: 34482824
[TBL] [Abstract][Full Text] [Related]
18. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
[TBL] [Abstract][Full Text] [Related]
19. Construction and verification of a novel prognostic risk model for kidney renal clear cell carcinoma based on immunity-related genes.
Liu Y; Wu D; Chen H; Yan L; Xiang Q; Li Q; Wang T
Front Genet; 2023; 14():1107294. PubMed ID: 36741315
[No Abstract] [Full Text] [Related]
20. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.
Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G
Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
